Goldman Sachs
CNST

Goldman Sachs’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Goldman Sachs’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,700
Closed -$531K – 6783
2021
Q1 		$531K Buy
22,700
+10,200
+82% +$309K ﹤0.01% 5072
2020
Q4 		$360K Buy
+12,500
New +$315K ﹤0.01% 4798

Goldman Sachs's CNST Position: Q3 2021 in Review

Goldman Sachs sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 458,096 shares — an estimated $15.5M sold.

Goldman Sachs first reported a position in CNST in Q3 2018 and held it in 10 quarters. The position peaked at $20.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Goldman Sachs reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 458,096 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $15.5M.
  • Goldman Sachs first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 10 quarters.
  • Goldman Sachs's Constellation Pharmaceuticals, Inc. position peaked at $20.5M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.